Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MNKD

Mannkind Corp

Dec 07 • 02:35PM ET

3.60

Dollar change +0.01
Percentage change 0.28	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.12	Insider Own	3.52%	Shs Outstand	263.79M	Perf Week	-0.55%
Market Cap	970.45M	Forward P/E	32.73	EPS next Y	0.11	Insider Trans	-0.61%	Shs Float	260.09M	Perf Month	-5.26%
Income	-31.29M	PEG	-	EPS next Q	0.01	Inst Own	51.29%	Short Float / Ratio	14.93% / 15.74	Perf Quarter	-16.08%
Sales	176.55M	P/S	5.50	EPS this Y	87.25%	Inst Trans	8.67%	Short Interest	38.82M	Perf Half Y	-12.62%
Book/sh	-0.93	P/B	-	EPS next Y	353.85%	ROA	-10.19%	Target Price	6.92	Perf Year	-21.23%
Cash/sh	0.52	P/C	6.88	EPS next 5Y	35.60%	ROE	-	52W Range	3.38 - 5.75	Perf YTD	-31.69%
Dividend	-	P/FCF	-	EPS past 5Y	21.35%	ROI	-31.25%	52W High	-37.39%	Beta	1.32
Dividend %	-	Quick Ratio	2.06	Sales past 5Y	62.97%	Gross Margin	65.55%	52W Low	6.67%	ATR	0.17
Employees	395	Current Ratio	2.34	Sales Q/Q	56.14%	Oper. Margin	-5.30%	RSI (14)	44.08	Volatility	5.10% 5.04%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	111.49%	Profit Margin	-17.72%	Rel Volume	0.52	Prev Close	3.59
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 07 AMC	Payout	-	Avg Volume	2.47M	Price	3.60
Recom	1.33	SMA20	-0.96%	SMA50	-7.34%	SMA200	-15.23%	Volume	1,017,314	Change	0.28%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-10-23	Initiated	Wedbush	Outperform	$10
May-14-21	Initiated	RBC Capital Mkts	Sector Perform	$5
Dec-24-19	Initiated	Oppenheimer	Outperform	$2.50
Oct-25-19	Initiated	Cantor Fitzgerald	Overweight	$3
May-14-19	Initiated	BTIG Research	Buy	$3
Mar-04-19	Initiated	SVB Leerink	Outperform	$3
Feb-22-19	Initiated	SVB Leerink	Outperform	$3
Feb-28-18	Downgrade	Maxim Group	Hold → Sell	$1
Nov-01-17	Downgrade	Maxim Group	Buy → Hold
Oct-10-17	Initiated	H.C. Wainwright	Buy	$7
Oct-06-17	Reiterated	Maxim Group	Buy	$4 → $7
Aug-11-17	Initiated	Maxim Group	Buy	$4
May-10-16	Reiterated	RBC Capital Mkts	Underperform	$0.15 → $0.20
May-10-16	Reiterated	Piper Jaffray	Underweight	$0.05 → $0.10
Jan-06-16	Reiterated	RBC Capital Mkts	Underperform	$1 → $0.15
Jan-06-16	Reiterated	Piper Jaffray	Underweight	$1.50 → $0.05
Nov-04-15	Downgrade	RBC Capital Mkts	Outperform → Underperform	$9 → $1
Sep-09-15	Downgrade	Piper Jaffray	Neutral → Underweight
Aug-03-15	Reiterated	RBC Capital Mkts	Outperform	$10 → $9
May-11-15	Reiterated	MLV & Co	Hold	$7 → $4

Show Previous Ratings

Nov-08-23 03:27PM	MannKind Corporation (NASDAQ:MNKD) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 09:15PM	MannKind (MNKD) Q3 2023 Earnings Call Transcript (Motley Fool)
05:30PM	MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
04:12PM	MannKind: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	MannKind Corporation Reports 2023 Third Quarter Financial Results (GlobeNewswire)
06:15AM	Loading…
Nov-06-23 06:15AM	MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes (GlobeNewswire) -7.07%
Nov-01-23 10:01AM	Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks) -6.06%
Oct-31-23 04:00PM	MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023 (GlobeNewswire)
Oct-30-23 06:15AM	MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent (GlobeNewswire) +6.39%
Sep-07-23 07:08AM	7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth (InvestorPlace)
Sep-05-23 06:00AM	MannKind Corporation Announces Participation at Upcoming Conferences (GlobeNewswire)
Aug-28-23 06:30PM	12 Best High Risk Penny Stocks to Buy Now (Insider Monkey)
Aug-14-23 12:44PM	3 Biotech Stocks to Sell in August Before They Crash and Burn (InvestorPlace)
Aug-08-23 05:16PM	Why MannKind Stock Soared 19% Higher on Tuesday (Motley Fool) +18.48%
11:33AM	Q2 2023 MannKind Corp Earnings Call (Thomson Reuters StreetEvents)
12:00AM	Loading…
12:00AM	MannKind (MNKD) Q2 2023 Earnings Call Transcript (Motley Fool)
Aug-07-23 06:00PM	Here's What Key Metrics Tell Us About MannKind (MNKD) Q2 Earnings (Zacks)
05:25PM	MannKind (MNKD) Reports Break-Even Earnings for Q2 (Zacks)
04:16PM	MannKind: Q2 Earnings Snapshot (AP Finance)
04:00PM	MannKind Corporation Reports 2023 Second Quarter Financial Results (GlobeNewswire)
Aug-01-23 06:00AM	MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jul-31-23 04:00PM	MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023 (GlobeNewswire)
Jul-13-23 07:31AM	Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now (InvestorPlace)
07:00AM	7 Biotech Stocks to Sell in July (InvestorPlace)
Jun-22-23 06:05AM	MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D) (GlobeNewswire)
Jun-11-23 08:05AM	Governor Ned Lamont to Tour MannKind June 12 as It Reaches a Manufacturing Milestone (GlobeNewswire)
May-28-23 07:49PM	7 Overvalued Penny Stocks to Sell Before June 2023 (InvestorPlace)
May-24-23 08:30AM	Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer (GlobeNewswire)
May-23-23 09:50AM	3 Biotech Stocks to Avoid Like the Plague (InvestorPlace)
May-10-23 12:02PM	Why Shares of MannKind Are Up Wednesday (Motley Fool) +15.79%
06:00AM	Loading…
06:00AM	MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 11:30PM	MannKind (MNKD) Q1 2023 Earnings Call Transcript (Motley Fool)
08:21PM	CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results (GlobeNewswire)
05:15PM	MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:18PM	MannKind: Q1 Earnings Snapshot (AP Finance)
04:00PM	Mannkind Corporation Reports 2023 First Quarter Financial Results (GlobeNewswire)
01:41PM	MannKind Corporation (NASDAQ:MNKD) is favoured by institutional owners who hold 54% of the company (Simply Wall St.)
May-02-23 05:00PM	MannKind Corporation to Hold 2023 First Quarter Financial Results Conference Call on May 9, 2023 (GlobeNewswire) -6.06%
Mar-27-23 04:05PM	Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer (GlobeNewswire)
Mar-14-23 02:26PM	Breakeven On The Horizon For MannKind Corporation (NASDAQ:MNKD) (Simply Wall St.)
Mar-07-23 05:00PM	MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Feb-24-23 01:30AM	MannKind (MNKD) Q4 2022 Earnings Call Transcript (Motley Fool)
Feb-23-23 04:00PM	MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
Feb-22-23 06:05AM	MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference (GlobeNewswire)
Feb-16-23 05:00PM	MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023 (GlobeNewswire)
Feb-15-23 12:46PM	As MannKind Corporation (NASDAQ:MNKD) gains 6.3%, insiders who bought last year may be wishing they had bet higher (Simply Wall St.)
Feb-10-23 05:00PM	Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-09-23 08:50AM	Here's What Could Help MannKind (MNKD) Maintain Its Recent Price Strength (Zacks)
Jan-24-23 06:00AM	MannKind Corporation to Participate in the Lytham Partners Investor Select Conference (GlobeNewswire) +6.79%
Jan-23-23 06:05AM	MannKinds Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease (GlobeNewswire)
Jan-18-23 08:00AM	3 Biotech Stocks Under $15 Worth a Second Look in 2023 (Motley Fool)
Jan-17-23 06:36AM	MannKind's (NASDAQ:MNKD) investors will be pleased with their impressive 183% return over the last three years (Simply Wall St.) -5.38%
Jan-05-23 06:00AM	MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-31-22 07:11AM	Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 44% Undervaluation? (Simply Wall St.)
Dec-06-22 09:55AM	After Golden Cross, MannKind (MNKD)'s Technical Outlook is Bright (Zacks)
Nov-30-22 12:29PM	MannKind Corporation (NASDAQ:MNKD) is a favorite amongst institutional investors who own 52% (Simply Wall St.) +5.64%
Nov-10-22 06:05AM	MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting (GlobeNewswire) +10.10%
05:31AM	MannKind Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-08-22 04:30PM	MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript (Motley Fool)
09:15AM	MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	MannKind Corporation Reports 2022 Third Quarter Financial Results (GlobeNewswire)
Nov-01-22 06:00AM	MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022 (GlobeNewswire)
Sep-29-22 11:38AM	7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up (InvestorPlace) -5.97%
06:13AM	When Can We Expect A Profit From MannKind Corporation (NASDAQ:MNKD)? (Simply Wall St.)
Sep-21-22 05:00PM	MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Sep-19-22 06:00AM	7 Penny Stocks That Actually Have a Buy Rating (InvestorPlace)
Sep-08-22 01:18PM	A number of insiders bought MannKind Corporation (NASDAQ:MNKD) stock last year, which is great news for shareholders (Simply Wall St.) +5.32%
Sep-06-22 06:15AM	Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine (GlobeNewswire) -5.29%
Sep-01-22 06:00AM	MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) +9.04%
Aug-25-22 09:09AM	10 Stocks That Jumped After Jim Cramers Negative Call (Insider Monkey)
Aug-19-22 06:18AM	Analysts Are Betting On MannKind Corporation (NASDAQ:MNKD) With A Big Upgrade This Week (Simply Wall St.)
Aug-16-22 09:03AM	Jim Cramer Recommends Selling These 10 Stocks in August (Insider Monkey)
Aug-10-22 07:19AM	MannKind's (NASDAQ:MNKD) investors will be pleased with their stellar 268% return over the last three years (Simply Wall St.)
05:30AM	MannKind Corporation (MNKD) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 05:15PM	MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.98%
05:00PM	Edited Transcript of MNKD.OQ earnings conference call or presentation 9-Aug-22 9:00pm GMT (Thomson Reuters StreetEvents)
04:00PM	MannKind Corporation Reports 2022 Second Quarter Financial Results (GlobeNewswire)
Aug-02-22 06:00AM	MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022 (GlobeNewswire) +10.06%
Aug-01-22 07:35PM	Why Shares of MannKind Corporation Climbed 10.4% on Monday (Motley Fool)
06:00AM	MannKind Corporation to Participate in the BTIG Biotechnology Conference (GlobeNewswire)
Jul-26-22 10:13AM	What's in Store for United Therapeutics' (UTHR) Q2 Earnings? (Zacks)
Jun-20-22 09:28AM	Allogene Therapeutics (ALLO) Moves 16.4% Higher: Will This Strength Last? (Zacks)
07:22AM	What Is The Ownership Structure Like For MannKind Corporation (NASDAQ:MNKD)? (Simply Wall St.)
Jun-03-22 10:00AM	Mannkind to Host Product Theater and Booth at the American Diabetes Associations 82nd Scientific Sessions in New Orleans, June 3-7 (GlobeNewswire) +11.35%
May-25-22 10:16AM	United Therapeutics (UTHR) Gains on Tyvaso DPI Approval (Zacks)
May-24-22 06:00AM	MannKinds Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI (GlobeNewswire)
May-19-22 06:00AM	MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell (GlobeNewswire) +10.03%
May-17-22 06:06AM	MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma (GlobeNewswire) +9.80%
May-09-22 06:00AM	MannKind Corporation Participating at Upcoming Conferences (GlobeNewswire) -6.10%
May-06-22 01:30AM	MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript (Motley Fool)
May-05-22 05:25PM	MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	MannKind Corporation Reports 2022 First Quarter Financial Results (GlobeNewswire)
May-04-22 06:15PM	Regenxbio (RGNX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Apr-28-22 06:00AM	MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022 (GlobeNewswire)
Apr-27-22 10:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:05AM	MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30 (GlobeNewswire)
Apr-21-22 10:38AM	Loss-Making MannKind Corporation (NASDAQ:MNKD) Expected To Breakeven In The Medium-Term (Simply Wall St.)
Mar-28-22 06:05AM	MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference (GlobeNewswire)
Mar-22-22 06:05AM	MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit (GlobeNewswire) +5.20%
Mar-08-22 06:05AM	MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference (GlobeNewswire)

MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Castagna Michael	Chief Executive Officer	Nov 01	Sale	4.25	10,000	42,500	2,349,147	Nov 02 09:00 PM
Castagna Michael	Chief Executive Officer	Oct 02	Sale	4.61	10,000	46,100	2,359,147	Oct 02 09:00 PM
Castagna Michael	Chief Executive Officer	Sep 01	Sale	4.61	10,000	46,100	2,436,039	Sep 05 09:00 PM
Thomson David	EVP Genl Counsel & Secretary	Aug 28	Sale	4.78	8,100	38,738	798,835	Aug 28 09:00 PM
Castagna Michael	Chief Executive Officer	Aug 01	Sale	4.57	10,000	45,686	2,496,735	Aug 01 09:00 PM
Castagna Michael	Chief Executive Officer	Jul 03	Sale	4.07	10,000	40,701	2,506,735	Jul 05 06:00 AM
Castagna Michael	Chief Executive Officer	Jun 01	Sale	4.53	10,000	45,302	2,516,735	Jun 02 09:00 PM
Castagna Michael	Chief Executive Officer	May 26	Sale	4.50	75,000	337,335	2,526,735	May 26 09:00 PM
Castagna Michael	Chief Executive Officer	May 25	Sale	4.59	75,000	344,468	2,601,735	May 26 09:00 PM
Castagna Michael	Chief Executive Officer	May 24	Sale	4.69	150,000	702,780	2,331,735	May 24 09:00 PM
Thomson David	EVP Genl Counsel & Secretary	May 24	Sale	4.68	95,576	447,754	735,263	May 24 09:00 PM
Binder Steven B.	Chief Financial Officer	May 24	Sale	4.67	47,810	223,512	838,324	May 24 09:00 PM
Castagna Michael	Chief Executive Officer	May 05	Sale	4.00	10,000	40,000	2,020,128	May 05 09:00 PM
Castagna Michael	Chief Executive Officer	Apr 03	Sale	4.13	10,000	41,287	2,030,128	Apr 05 09:00 PM
Castagna Michael	Chief Executive Officer	Mar 01	Sale	5.27	10,000	52,748	2,040,128	Mar 03 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MNKD

Mannkind Corp

Upgrade your FINVIZ experience